abstract |
The present invention relates to novel substituted oxazolidinones of formula (I), processes for their preparation, their use for the treatment and / or prevention of diseases, and medicaments for the treatment and / or prevention of diseases, in particular thromboembolic disorders Relating to their use for manufacturing. Formula (I) where R ′ = Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih) or (Ii). |